-
Beyond the Surface: Health Technology Assessment and Reimbursement for Inflammatory or Autoimmune Disorders With Cosmetic and Dermatological Manifestations
Sep 9, 2025, 16:22 PM -
From Cost Containment to Modernization: Market Access Updates Across the EU4 and the UK in 2025
Sep 9, 2025, 16:22 PM -
DARAH Project: Deploying a Datashield Federated Network in Real-World Healthcare Environments
Sep 9, 2025, 16:22 PM -
Leveraging Real-World Data to Conduct Noninterventional Studies in Rare Disease Populations: Lessons in Scalability and Data Access From Three Observational Studies
Sep 9, 2025, 16:22 PM -
Frequency and Impact of External Comparator Arms in Oncology HTA Assessments With Single-Arm Trials in the UK, France, and Germany From 2014 to 2024
Sep 9, 2025, 16:22 PM -
Can Generative AI Automate Health Economic Model Verification?
Sep 9, 2025, 16:22 PM -
Current Status of Home-Healthcare Pilot Programs in South Korea and Policy Discussions for Institutionalization
Sep 9, 2025, 16:22 PM -
Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Explaining Psychiatric Comorbidities in Patients With Skin Conditions: The Importance of Clinical Characteristics and Patient-Reported Disease Impact
Sep 9, 2025, 16:22 PM -
Human Alignment on Evaluating LLMs for Literature Review Extraction
Sep 9, 2025, 16:22 PM -
Hospital Systemic Treatment for HepatoCarcinoma: The HOSTHECA Study
Sep 9, 2025, 16:22 PM -
Balancing Innovation and Propriety: The Question of Copyright Holder’s Opinions on GenAI Usage While Localizing Their Intellectual Property
Sep 9, 2025, 16:22 PM -
Estimated Healthcare Resource Utilization and Costs Associated With Semaglutide Life Expectancy Gains in a Real-World Population With CVD and Overweight or Obesity in the United Kingdom
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of Reimbursement Decisions for Targeted Therapies and Immunotherapies in NSCLC Across EU HTA Bodies
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Ovarian Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Analysis of Pharmacists' Awareness on Post COVID-19 Conditions and Implementation in Postgraduate Education in Ukraine
Sep 9, 2025, 16:22 PM -
Measuring the Disease Burden and Quality of Life From the Schizophrenia Caregivers’ Perspective
Sep 9, 2025, 16:22 PM -
International Reference Pricing (IRP) Analysis for Original Medicines in Türkiye in 2024
Sep 9, 2025, 16:22 PM -
How Will Patient Registry Data Play a Role in Joint Clinical Assessment (JCA) for Rare Diseases Learnings From National Health Technology Assessments (HTAs)?
Sep 9, 2025, 16:22 PM -
NMAs of Systemic Therapies for Advanced Biliary Tract Cancer: A Systematic Review and Critical Appraisal Using RoB NMA
Sep 9, 2025, 16:22 PM
